205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.84%
Revenue growth above 1.5x NXPI's 3.21%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
16.44%
Gross profit growth above 1.5x NXPI's 0.13%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
26.41%
Positive EBIT growth while NXPI is negative. John Neff might see a substantial edge in operational management.
13.75%
Positive operating income growth while NXPI is negative. John Neff might view this as a competitive edge in operations.
0.48%
Positive net income growth while NXPI is negative. John Neff might see a big relative performance advantage.
2.63%
Positive EPS growth while NXPI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
No Data
No Data available this quarter, please select a different quarter.
-0.55%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.36%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-99.94%
Dividend reduction while NXPI stands at 0.12%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
83.07%
OCF growth above 1.5x NXPI's 37.88%. David Dodd would confirm a clear edge in underlying cash generation.
86.67%
FCF growth similar to NXPI's 94.26%. Walter Schloss would attribute it to parallel capital spending and operational models.
-2.77%
Negative 10Y revenue/share CAGR while NXPI stands at 79.10%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
20.39%
5Y revenue/share CAGR under 50% of NXPI's 77.31%. Michael Burry would suspect a significant competitive gap or product weakness.
68.07%
Positive 3Y CAGR while NXPI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
175.37%
10Y OCF/share CAGR above 1.5x NXPI's 104.58%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
228.76%
5Y OCF/share CAGR above 1.5x NXPI's 107.18%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
182.00%
Positive 3Y OCF/share CAGR while NXPI is negative. John Neff might see a big short-term edge in operational efficiency.
102.53%
Net income/share CAGR above 1.5x NXPI's 36.73% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-1.52%
Negative 5Y net income/share CAGR while NXPI is 328.95%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
253.22%
Positive short-term CAGR while NXPI is negative. John Neff would see a clear advantage in near-term profit trajectory.
186.13%
Below 50% of NXPI's 1254.96%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
1.13%
Below 50% of NXPI's 18.89%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
12.65%
Below 50% of NXPI's 42.98%. Michael Burry suspects a serious short-term disadvantage in building book value.
-99.93%
Cut dividends over 10 years while NXPI stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-99.92%
Negative 5Y dividend/share CAGR while NXPI stands at 169.49%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-99.93%
Negative near-term dividend growth while NXPI invests at 20.43%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
0.68%
AR growth well above NXPI's 1.04%. Michael Burry fears inflated revenue or higher default risk in the near future.
-3.66%
Inventory is declining while NXPI stands at 0.47%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.44%
Asset growth above 1.5x NXPI's 0.28%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.15%
1.25-1.5x NXPI's 3.20%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-0.83%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
6.90%
R&D growth drastically higher vs. NXPI's 4.75%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
20.35%
We expand SG&A while NXPI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.